NANCY SMITH
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical BALTIMORE, MD NPI 1295877256
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical MD Amarin Pharma Inc. All categories
General Payments — all program years on this page
$444.44
- Category: General Payments
- Program years: PY2022–2023
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $262.40 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $262.40 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amarin Pharma Inc. | $99.20 | 1 |
| Acerta Pharma LLC | $41.17 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.37 | 2 |
| Mallinckrodt Hospital Products Inc. | $39.12 | 1 |
| Molnlycke Health Care US, LLC | $21.42 | 1 |
| Retrophin, Inc. | $21.12 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1000912565 | Amarin Pharma Inc. | $99.20 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015300165 | AstraZeneca Pharmaceuticals LP | $24.97 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015746761 | AstraZeneca Pharmaceuticals LP | $16.20 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1026943365 | Molnlycke Health Care US, LLC | $21.42 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1042996785 | Mallinckrodt Hospital Products Inc. | $39.12 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059574875 | Travere Therapeutics, Inc. | $21.12 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 993419317 | Novartis Pharmaceuticals Corporation | $21.05 | 10/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 993419319 | Novartis Pharmaceuticals Corporation | $19.32 | 11/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.